title: What does HDL do? A new mechanism to slow atherogenesis--but a new problem in type 2 diabetes mellitus.
authors: Section of Endocrinology, Diabetes, & Metabolism, Department of Medicine, Temple University School of Medicine, 3322 North Broad Street, Philadelphia, PA 19140, USA. kjwilliams@temple.edu
authors: Kevin Jon
authors: KJ
authors: Williams
mesh_terms: D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001018:Aortic Diseases / Q000517:prevention & control*; D016632:Apolipoprotein A-I / Q000494:pharmacology*; D001057:Apolipoproteins E / Q000172:deficiency*; D050197:Atherosclerosis / Q000517:prevention & control*; D005260:Female; D008074:Lipoproteins / Q000494:pharmacology*; D010446:Peptide Fragments / Q000494:pharmacology*
chemical_list: D000924:Anticholesteremic Agents; D016632:Apolipoprotein A-I; D001057:Apolipoproteins E; D008074:Lipoproteins; D010446:Peptide Fragments